PHAT
Phathom Pharmaceuticals Inc
NASDAQ: PHAT · HEALTHCARE · BIOTECHNOLOGY
$11.78
+3.97% today
Updated 2026-04-29
Market cap
$935.69M
P/E ratio
—
P/S ratio
5.34x
EPS (TTM)
$-3.03
Dividend yield
—
52W range
$2 – $18
Volume
1.2M
Phathom Pharmaceuticals Inc (PHAT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+40.5%
Last 4 quarters
Revenue YoY growth
+94.1%
Most recent quarter
EPS YoY growth
+92.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+3.0%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+12.2%
2025-08-07
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-03 | $-0.08 | +81.0% | $11.46 | $11.06 | -3.5% |
| 2025-10-30 | $-0.15 | +68.1% | $13.53 | $13.55 | +0.1% |
| 2025-08-07 | $-0.79 | +13.2% | $8.68 | $9.74 | +12.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.42 | $-0.08 | +81.0% | $57.58M | +94.1% |
| 2025-09-30 | $-0.47 | $-0.15 | +68.1% | $49.50M | +202.7% |
| 2025-06-30 | $-0.91 | $-0.79 | +13.2% | $39.50M | +439.4% |
| 2025-03-31 | $-1.07 | $-1.07 | -0.4% | $28.52M | +1391.6% |
| 2024-12-31 | $-1.08 | $-1.05 | +2.8% | $29.66M | +4249.6% |
| 2024-09-30 | $-1.49 | $-1.32 | +11.4% | $16.35M | — |
| 2024-06-30 | $-1.38 | $-1.56 | -13.0% | $7.32M | — |
| 2024-03-31 | $-1.31 | $-1.42 | -8.4% | $1.91M | — |
| 2023-12-31 | $-1.08 | $-1.39 | -28.7% | $682000.00 | — |
| 2023-09-30 | $-0.89 | $-0.76 | +14.6% | — | — |
| 2023-06-30 | $-0.98 | $-0.84 | +14.3% | — | — |
Frequently asked questions
Has Phathom Pharmaceuticals Inc beaten earnings estimates?
Phathom Pharmaceuticals Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +40.5% over the last 4 quarters.
How does PHAT stock react to earnings?
PHAT stock has moved an average of +3.0% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Phathom Pharmaceuticals Inc's revenue growth rate?
Phathom Pharmaceuticals Inc reported year-over-year revenue growth of +94.1% in its most recent quarter, with EPS growing +92.4% year-over-year.